Cosmo Bio Company,Limited (3386.T)

JPY 1154.0

(0.17%)

Long Term Debt Summary of Cosmo Bio Company,Limited

  • Cosmo Bio Company,Limited's latest annual long term debt in 2023 was - JPY , down 0.0% from previous year.
  • Cosmo Bio Company,Limited's latest quarterly long term debt in 2024 Q2 was - JPY , down 0.0% from previous quarter.
  • Cosmo Bio Company,Limited reported annual long term debt of - JPY in 2022, down 0.0% from previous year.
  • Cosmo Bio Company,Limited reported annual long term debt of - JPY in 2021, down 0.0% from previous year.
  • Cosmo Bio Company,Limited reported quarterly long term debt of - JPY for 2024 Q2, down 0.0% from previous quarter.
  • Cosmo Bio Company,Limited reported quarterly long term debt of - JPY for 2023 Q3, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Cosmo Bio Company,Limited (2023 - 2019)

Historical Annual Long Term Debt of Cosmo Bio Company,Limited (2023 - 2019)

Year Long Term Debt Long Term Debt Growth
2023 - JPY 0.0%
2022 - JPY 0.0%
2021 - JPY 0.0%
2020 - JPY 0.0%
2019 - JPY 0.0%

Peer Long Term Debt Comparison of Cosmo Bio Company,Limited

Name Long Term Debt Long Term Debt Difference
Shin Nippon Biomedical Laboratories, Ltd. 18.14 Billion JPY 100.0%
DNA Chip Research Inc. - JPY NaN%
H.U. Group Holdings, Inc. 60.1 Billion JPY 100.0%
FALCO HOLDINGS Co., Ltd. 148 Million JPY 100.0%
BML, Inc. 3.73 Billion JPY 100.0%
Human Metabolome Technologies, Inc. 11.34 Million JPY 100.0%
Precision System Science Co., Ltd. 289.67 Million JPY 100.0%